NCT03616964 A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE-BRAVE II) Status COMPLETED Phase PHASE3
NCT03616912 A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus Status TERMINATED Phase PHASE3
NCT03610971 Treatment Free Remission After Combination Therapy With Ruxolitinib Plus Tyrosine Kinase Inhibitors Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03607487 A Placebo-Controlled Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa Status COMPLETED Phase PHASE2
NCT03599713 A Study of INCMGA00012 in Metastatic Merkel Cell Carcinoma (POD1UM-201) Status COMPLETED Phase PHASE2
NCT03597295 A Study of INCMGA00012 in Squamous Carcinoma of the Anal Canal Following Platinum-Based Chemotherapy (POD1UM-202) Status COMPLETED Phase PHASE2
NCT03589651 INCMGA00012 in Combination With Other Therapies in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT03584516 GRAVITAS-309: Itacitinib and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease Status TERMINATED Phase PHASE2/PHASE3
NCT03571321 Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia Status RECRUITING Phase PHASE1
NCT03570749 A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata Status COMPLETED Phase PHASE2/PHASE3
NCT03569371 A Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa Status COMPLETED Phase PHASE2
NCT03559270 A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis Status TERMINATED Phase PHASE3
NCT03538041 A Study of INCB050465 in Participants With Autoimmune Hemolytic Anemia Status COMPLETED Phase PHASE2
NCT03532295 Retifanlimab and Epacadostat in Combination With Radiation and Bevacizumab in Patients With Recurrent Gliomas Status COMPLETED Phase PHASE2
NCT03522142 A Study Exploring the Safety and Tolerability of INCB081776 in Participants With Advanced Malignancies Status TERMINATED Phase PHASE1
NCT03516708 Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT03514407 A Study of INCB059872 in Relapsed or Refractory Ewing Sarcoma Status TERMINATED Phase PHASE1
NCT03497273 Safety of Itacitinib in Combination With Corticosteroids for Treatment of Steroid-Naive Acute Graft-Versus-Host Disease in Japanese Subjects Status COMPLETED Phase PHASE1
NCT03471286 A Window of Opportunity Study to Investigate Mechanisms of Actions of Novel Therapeutic Agents in Patients With Resectable Solid Tumor Malignancies Status TERMINATED Phase PHASE1
NCT03435081 A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis Status COMPLETED Phase PHASE3